Erratum: Bim and Bad mediate imatinib-induced killing of Bcr/Abl + leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic (Proceedings of the National Academy of Sciences of the United States of America (October 3, 2006) 40, 103 (14907-14912) DOI: 10.1073/pnas.0606176103);Bim and Bad mediated imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 40, 2006, Pages 14907-14912

  Kuroda, Junya ^a,b,c   Puthalakath, Hamsa ^a   Cragg, Mark S ^a   Kelly, Priscilla N ^a,d   Bouillet, Philippe ^a   Huang, David C S ^a   Kimura, Shinya ^c   Ottmann, Oliver G ^e   Druker, Brian J ^f   Villunger, Andreas ^g   Roberts, Andrew W ^a   Strasser, Andreas ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e GOETHE UNIVERSITY   (Germany)

^f HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^g UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Apoptosis; Bcl 2; Cancer; Imatinib mesylate; Leukemia

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; ANTILEUKEMIC AGENT; BCR ABL PROTEIN; BETA ACTIN; BH3 PROTEIN; BIM PROTEIN; IMATINIB; PROTEIN; PROTEIN BAD; PROTEIN BCL 2; PROTEIN BMF; PROTEIN PUMA; UNCLASSIFIED DRUG; ABT-737; ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; BCL 2 BINDING PROTEIN, BIM; BCL-2-BINDING PROTEIN, BIM; BCR ABL TYROSINE KINASE; BCR-ABL TYROSINE KINASE; BIPHENYL DERIVATIVE; MEMBRANE PROTEIN; ONCOPROTEIN; PIPERAZINE DERIVATIVE; PROTEIN TYROSINE KINASE; PYRIMIDINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIM GENE; BMF GENE; CANCER RESISTANCE; CELL KILLING; CELL STRAIN K 562; CONTROLLED STUDY; GENE; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RNA INTERFERENCE; ANIMAL; CELL TRANSFORMATION; CHRONIC MYELOID LEUKEMIA; CYTOLOGY; CYTOTOXICITY; DRUG EFFECT; DRUG RESISTANCE; FETUS; GENETICS; LIVER; METABOLISM; MOUSE; MYELOID PROGENITOR CELL; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-ASSOCIATED DEATH PROTEIN; BIPHENYL COMPOUNDS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CYTOTOXICITY, IMMUNOLOGIC; DRUG RESISTANCE, NEOPLASM; FETUS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LIVER; MEMBRANE PROTEINS; MICE; MYELOID PROGENITOR CELLS; PIPERAZINES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRIMIDINES;

EID: 33749510073     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0608594103     Document Type: Erratum

References (28)

1. Deininger M, Buchdunger E, Druker BJ (2005) Blood 105:2640-2653.
2. Bhatia R, Holtz M, Niu N, Gray R, Snyder DS, Sawyers CL, Arber DA, Slovak ML, Forman SJ (2003) Blood 101:4701-4707.
3. Strasser A, O'Connor L, Dixit VM (2000) Annu Rev Biochem 69:217-245.
4. Green DR, Kroemer G (2004) Science 305:626-629.
5. Puthalakath H, Strasser A (2002) Cell Death Differ 9:505-512.
6. Huang DCS, Strasser A (2000) Cell 103:839-842.
7. Ferrao PT, Frost MJ, Siah SP, Ashman LK (2003) Blood 102:4499-4503.
8. Kuribara R, Honda H, Matsui H, Shinjyo T, Inukai T, Sugita K, Nakazawa S, Hirai H, Ozawa K, Inaba T (2004) Mol Cell Biol 24:6172-6183.
9. Essafi A, Fernandez de Mattos S, Hassen YA, Soeiro I, Mufti GJ, Thomas NS, Medema RH, Lam EW (2005) Oncogene 1-13.
10. Horita M, Andreu EJ, Benito A, Arbona C, Sanz C, Benet I, Prosper F, Fernandez-Luna JL (2000) J Exper Med 191:977-984.
11. Akiyama T, Bouillet P, Miyazaki T, Kadono Y, Chikuda H, Chung UI, Fukuda A, Hikita A, Seto H, Okada T, et al. (2003) EMBO J 22:6653-6664.
12. Ley R, Balmanno K, Hadfield K, Weston C, Cook SJ (2003) J Biol Chem 278:18811-18816.
13. Luciano F, Jacquel A, Colosetti P, Herrant M, Cagnol S, Pages G, Auberger P (2003) Oncogene 22:6785-6793.
14. Villunger A, Michalak EM, Coultas L, Müllauer F, Böck G, Ausserlechner MJ, Adams JM, Strasser A (2003) Science 302:1036-1038.
15. Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, Brennan J, MacLean KH, Han J, Chittenden T, Ihle JN, et al. (2003) Cancer Cell 4:321-328.
16. Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, et al. (2005) Nature 435:677-681.
17. Weber-Nordt RM, Egen C, Wehinger J, Ludwig W, Gouilleux-Gruart V, Mertelsmann R, Finke J (1996) Blood 88:809-816.
18. Komatsu N, Watanabe T, Uchida M, Mori M, Kirito K, Kikuchi S, Liu Q, Tauchi T, Miyazawa K, Endo H, et al. (2003) J Biol Chem 278:6411-6419.
19. Puthalakath H, Villunger A, O'Reilly LA, Beaumont JG, Coultas L, Cheney RE, Huang DCS, Strasser A (2001) Science 293:1829-1832.
20. Zha J, Harada H, Yang E, Jockei J, Korsmeyer SJ (1996) Cell 87:619-628.
21. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, Colman PM, Day CL, Adams JM, Huang DCS (2005) Mol Cell 17:393-403.
22. Kuroda J, Kimura S, Segawa H, Kobayashi Y, Yoshikawa T, Urasaki Y, Ueda T, Enjo F, Tokuda H, Ottmann OG, Maekawa T (2003) Blood 102:2229-2235.
23. Huang DCS, Hahne M, Schroeter M, Frei K, Fontana A, Villunger A, Newton K, Tschopp J, Strasser A (1999) Proc Natl Acad Sci USA 96:14871-14876.
24. Bouillet P, Robati M, Bath ML, Strasser A (2005) Cell Death Differ 12:831-833.
25. Bouillet P, Metcalf D, Huang DCS, Tarlinton DM, Kay TWH, Königen F, Adams JM, Strasser A (1999) Science 286:1735-1738.
26. Ranger AM, Zha J, Harada H, Datta SR, Danial NN, Gilmore AP, Kutok JL, Le Beau MM, Greenberg ME, Korsmeyer SJ (2003) Proc Natl Acad Sci USA 100:9324-9329.
27. Ogilvy S, Metcalf D, Print CG, Bath ML, Harris AW, Adams JM (1999) Proc Natl Acad Sci USA 96:14943-14948.
28. Hariharan I, Adams JM, Cory S (1988) Oncogene Res 3:1-13.